Immunotherapy: Tear down this wall.
作者信息
Harjes Ulrike
出版信息
Nat Rev Cancer. 2018 Apr;18(4):205. doi: 10.1038/nrc.2018.22. Epub 2018 Mar 9.
PMID:29520089
Abstract
摘要
相似文献
1
Immunotherapy: Tear down this wall.
Nat Rev Cancer. 2018 Apr;18(4):205. doi: 10.1038/nrc.2018.22. Epub 2018 Mar 9.
2
Nanobiologics: a real game changer for targeted immunotherapy.
Cardiovasc Res. 2019 May 1;115(6):e52-e53. doi: 10.1093/cvr/cvz078.
3
Immunotherapy: A therapeutic reservoir.
Nat Rev Cancer. 2018 Mar 22;18(4):206. doi: 10.1038/nrc.2018.23.
4
Modern immunotherapy of cancer.
Adv Surg. 1991;24:41-68.
5
Immunotherapy: Direct shot.
Nat Rev Immunol. 2018 Mar;18(3):149. doi: 10.1038/nri.2018.10. Epub 2018 Feb 16.
6
Genomics of Immunotherapy-Associated Hyperprogressors-Letter.
Clin Cancer Res. 2017 Oct 15;23(20):6374-6375. doi: 10.1158/1078-0432.CCR-17-1480.
7
Genomics of Immunotherapy-Associated Hyperprogressors-Response.
Clin Cancer Res. 2017 Oct 15;23(20):6376. doi: 10.1158/1078-0432.CCR-17-1990.
8
Immunotherapy: The power of perseverance.
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1775-1776. doi: 10.1016/j.jtcvs.2017.12.002. Epub 2017 Dec 9.
9
Immunotherapy: HLA genotype: good to be different.
Nat Rev Immunol. 2018 Feb;18(2):78-79. doi: 10.1038/nri.2017.220. Epub 2017 Dec 27.
10
Immunotherapy: Cancer immunotherapy and the value of cure.
Nat Rev Clin Oncol. 2018 May;15(5):268-270. doi: 10.1038/nrclinonc.2018.27. Epub 2018 Feb 20.
引用本文的文献
1
Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells.
Sci Adv. 2021 May 21;7(21). doi: 10.1126/sciadv.abd7455. Print 2021 May.
本文引用的文献
1
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis.
Nature. 2018 Feb 22;554(7693):538-543. doi: 10.1038/nature25492. Epub 2018 Feb 14.
2
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Nature. 2018 Feb 22;554(7693):544-548. doi: 10.1038/nature25501. Epub 2018 Feb 14.
Zotero 插件